Before the broad deal, Endo in September 2021 agreed to pay $50 million to settle opioid lawsuits in New York. In late 2021, the company reached a $63 million opioid settlement with Texas.

Endo pulled Opana from the market in 2017 at the request of the FDA over concerns about abuse. The drug has been the subject of lawsuits by local governments around the country that have accused ...

Endo spent $136 million on opioid litigation in 2021, and $32.7 million in the first quarter of 2022, according to its complaint. NOTE: This story has been updated to add a comment from the Oregon ...

Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, primarily operated ...

Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...

EAST WHITELAND — Endo, a pharmaceutical company that has its global headquarters in Chester County, is being acquired by Ireland’s Mallinckrodt in a cash-and-stock deal valued at $6.7 billion.

Mallinckrodt to Apply to Irish High Court for Approval of Scheme of Arrangement. DUBLIN and MALVERN, Pa., June 13, 2025/ PRNewswire/-- Mallinckrodt plc and Endo, Inc. today announced that their ...

Mallinckrodt plc ("Mallinckrodt") and Endo, Inc. (OTCQX: NDOI) ("Endo") today announced that their respective shareholders have provided the necessary shareholder approvals for the companies to ...